SCHEMBL3030388

SCHEMBL3030388

CCCC=CC=NS(=O)(=O)c1ccc(OC)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
F2 P00734 2/20 0.45
PRSS1 P07477 2/20 0.45
PRSS2 P07478 2/20 0.45
PRSS3 P35030 2/20 0.45
PKM P14618 5/20 0.43
GAA P10253 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
MMP13 P45452 6/20 0.40
MMP9 P14780 3/20 0.40
MMP1 P03956 2/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
PTGS2 P35354 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3030385 1.00 ALDH1A1 (0.50) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL3030387 1.00 ALDH1A1 (0.50) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL3025149 0.79 ALDH1A1 (0.60) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL3025148 0.79 ALDH1A1 (0.60) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL3025150 0.79 ALDH1A1 (0.60) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL3040083 0.75 ALDH1A1 (0.52) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL3040080 0.75 ALDH1A1 (0.52) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL3040078 0.75 ALDH1A1 (0.52) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL14446276 0.74 ALDH1A1 (0.70) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL10977644 0.74 ALDH1A1 (0.54) ALDH1A1F2PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8501658-B2 Enantioselective reactions catalyzed by chiral triazolium salts THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-08-06 US disclosed
US-20100210452-A1 ENANTIOSELECTIVE REACTIONS CATALYZED BY CHIRAL TRIAZOLIUM SALTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210452-A1 ENANTIOSELECTIVE REACTIONS CATALYZED BY CHIRAL TRIAZOLIUM SALTS IDH1, MDM4, PCNA ALDH1A1 1165/4885F2 3122/4885PRSS1 3921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.